Seaweed: a sustainable solution for greening drug manufacturing in the pursuit of sustainable healthcare
Open Access
- 27 February 2024
- journal article
- review article
- Published by Open Exploration Publishing
- Vol. 2 (1) , 50-84
Abstract
The environmental impact of drug manufacturing raises concerns about sustainability in healthcare. To address this, exploring alternative approaches to drug production is crucial. This review focuses on seaweed as a sustainable resource for greening drug manufacturing processes. Seaweed offers advantages such as renewability, abundance, and a positive environmental footprint. The review begins by providing an overview of sustainable drug manufacturing practices and the challenges faced in achieving sustainability. It then discusses seaweed as a sustainable resource, including cultivation techniques and environmental benefits. Seaweed has various applications in drug manufacturing, including extracting and purifying bioactive compounds with potential therapeutic properties. Seaweed’s role in developing green technologies, such as seaweed-based excipients, biodegradable packaging materials, and as a source of sustainable energy for drug manufacturing processes, is highlighted. The environmental and economic implications of incorporating seaweed-based solutions are discussed, emphasizing reduced carbon footprint and cost-effectiveness. Regulatory and industrial perspectives are addressed, examining challenges, and opportunities for implementing seaweed-based drug manufacturing. Collaboration between academia, industry, and regulatory bodies is crucial for successful integration. The review presents future directions and opportunities, including emerging trends and innovations in seaweed-based drug manufacturing, areas for further research, policy development, and industry engagement recommendations. Incorporating seaweed into drug production facilitates a reduction in environmental impact, promotes resource efficiency, and contributes to sustainable healthcare. This review showcases seaweed-based solutions as a means to foster a greener future for drug manufacturing, addressing environmental concerns, and promoting sustainability.Keywords
This publication has 239 references indexed in Scilit:
- Seaweed Farming: An Environmental and Societal Perspective2023
- Cultivation of Gracilaria gracilis in an Aquaculture System at Mondego River (Portugal) Estuary Adjacent Terrain2021
- Exploring, harnessing and conserving marine genetic resources towards a sustainable seaweed aquaculturePlants, People, Planet, 2021
- A Glimpse into Green Chemistry Practices in the Pharmaceutical IndustryChemSusChem, 2020
- Hydrothermal liquefaction of Malaysia's algal biomass for high‐quality bio‐oil productionEngineering in Life Sciences, 2019
- Overview of Goal and Scope Definition in Life Cycle Assessment2016
- Alginate dressings for venous leg ulcersCochrane Database of Systematic Reviews, 2015
- Extraction and Characterization of Bioactive Compounds with Health Benefits from Marine Resources: Macro and Micro Algae, Cyanobacteria, and Invertebrates2011
- Solving the coastal eutrophication problem by large scale seaweed cultivation2004
- The World Health Organization and the Pharmaceutical IndustryAdverse Drug Reactions and Toxicological Reviews, 2002